Abeyatech, LLC Merges with Azenta US, Inc
2910 Fortune Circle West, Suite E
Indianapolis, IN 46241
Company Merger Announcement
Dear Valued Customer,
On May 1, 2022, as part of an acquisition, the assets of Abeyatech, LLC will be merged into Azenta US, Inc. Azenta is a pure play life sciences company with deep expertise in sample-based solutions and genomic services. Our service level and commitment to you will remain unchanged during this transition. We are requesting that these changes be made within 90 days. All new PO’s should be issued to Azenta starting May 1, 2022, and should be submitted to SalesOrders.NA@Azenta.com. You may continue to copy Orders@Abeyancecryo.com during this transitional period as well.
Any current agreement you have with Abeyatech, LLC, together with any exhibits, schedules, work orders, purchase orders, quality agreements, or data processing agreements, thereunder, including any other agreements you may enter into after the date of this letter and before May 1, 2022 (the “Agreements”), will need to be assigned to Azenta US, Inc.. This letter constitutes notice to you of the intended assignments. Accordingly, as of May 1, 2022, Azenta US, Inc., will accept and assume all rights and obligations under the Agreements, and shall be substituted in full for its predecessor as a party to the Agreements in all respects. If we do not receive an objection from you by April 29, 2022, and/or you continue to perform your obligations under the Agreements, then you will be deemed to have consented to the assignment.
Should you have questions or need assistance walking through this, please reach out to AzentaHelp@Azenta.com , and one of our team members will be happy to assist you. We look forward to continuing and enhancing our relationship under the Azenta name.
Azenta Life Sciences Leadership Team